GERD surgery vs PPIs
This article was originally published in The Tan Sheet
Executive Summary
Patients with gastroesophageal reflux disease (GERD) who opt for the surgical procedure laparoscopic Nissen fundoplication (LNF) have fewer symptoms long-term than those who manage their condition with proton-pump inhibitors like Prilosec OTC, according to research presented during Digestive Disease Week in Los Angeles, Calif. The study randomly divided 98 chronic GERD patients requiring long-term therapy. One group was treated with PPI, and the other underwent LNF. The researchers checked symptoms every three months and conducted a 24-hour pH test after one year. While symptoms and pH levels improved in both the PPI and surgery groups, the one-year follow up showed surgical patients experienced a significant improvement in symptoms, climbing from 73.3 to 90.2 on a 100-point global rating scale that measured patient satisfaction with symptom control, Mehran Anvari, McMaster University in Ontario, et al., conclude. Meanwhile, the PPI patients' symptoms remained stable. "This minimally invasive surgical procedure may allow some patients to manage GERD symptoms and forego a long-term drug regimen." The study runs counter to a report from Tufts-New England Medical Center Evidence-based Practice Center that concluded that PPIs and surgery are similar in relieving symptoms and decreasing esophageal acid exposure 1("The Tan Sheet" Dec. 19, 2005, p. 5)...
You may also be interested in...
Proton Pump Inhibitors Match Gastro Surgery For GERD Treatment – AHRQ
Prilosec OTC and other PPIs are as effective as surgery for the treatment of gastroesophageal reflux disease (GERD), according to a report released Dec. 14 by the Agency for Healthcare Research & Quality
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.